WSB2 degrades p53, which leads to decreased IGFBP3 expression and increased AKT Ser 473 phosphorylation, subsequently activating mTOR signaling and contributing to HCC carcinogenesis and metastasis (outlined in Fig. 8). This evidence concerns the gene TP53 and hepatocellular carcinoma.